🔎 Trials Near Me

Gara Jalqabaatti › Leukemia Myeloidii Hamaa › New York › Rochester

Qorannoo klinikaalii Leukemia Myeloidii Hamaa Rochester, NY keessatti

Qorannoo 16 Leukemia Myeloidii Hamaa f Rochester fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Namoota walitti qabaa jiraSadarkaa 2
  • Rochester General Hospital, Rochester
  • University of Rochester, Rochester
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT05564390

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

Namoota walitti qabaa jiraSadarkaa 2
  • University of Rochester, Rochester
Umuriin 18 hanga 59 · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT05554393

A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

Namoota walitti qabaa jiraSadarkaa 3
  • University of Rochester Medical Center, Rochester
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06852222

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

Namoota walitti qabaa jiraSadarkaa 2
  • University of Rochester, Rochester
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT06672146

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

Namoota walitti qabaa jiraSadarkaa 2
  • University of Rochester, Rochester
Umuriin 18 hanga 59 · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT05554406

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

Namoota walitti qabaa jiraSadarkaa 2
  • University of Rochester, Rochester
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT06317649

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Namoota walitti qabaa jiraSadarkaa 3
  • University of Rochester, Rochester
6 Months – 21 Years · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT04293562

A Telehealth Advance Care Planning Intervention

Namoota walitti qabaa jira
  • University of Rochester, Rochester
Umuriin 60 fi ol · Saalaa hunda · Haaromfame 11-Ful-2026 · NCT05875805

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Namoota walitti qabaa jiraSadarkaa 1
  • Wilmot Cancer Institute, University of Rochester, Rochester
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Hag-2026 · NCT06001788

Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT

Namoota walitti qabaa jiraSadarkaa 3
  • University of Rochester Medical Center (URMC), Rochester
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 17-Ado-2026 · NCT05429632

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Strong Memorial Hospital/University of Rochester, Rochester
Umuriin hundi · Saalaa hunda · Haaromfame 06-Ado-2026 · NCT01351545

A Decisional Intervention for Older Adults With Acute Myeloid Leukemia and Their Caregivers

Namoota walitti qabaa jira
  • University of Rochester Medical Center, Rochester
Umuriin 60 fi ol · Saalaa hunda · Haaromfame 06-Ado-2026 · NCT06697600

Hyperbaric Oxygen Therapy and Allogeneic Peripheral Blood Stem Cell (PBSC) Transplant

Namoota walitti qabaa jiraSadarkaa jalqabaa 1
  • Wilmot Cancer Institute, University of Rochester, Rochester
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 03-Wax-2026 · NCT03964506

A Study of CTX-712 in Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes

Namoota walitti qabaa jiraSadarkaa 1/2
  • The University of Rochester, Rochester
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 13-Elb-2026 · NCT05732103

Monitoring Minimal Residual Disease of Patients With Acute Myelogenous Leukemia or High Grade Myelodysplastic Syndrome

Namoota walitti qabaa jiraQorannoo ilaalaa
  • University of Rochester Medical Center, Rochester
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Ful-2025 · NCT01311258

Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia

Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
  • University of Rochester, Rochester
Umuriin 18 hanga 120 · Saalaa hunda · Haaromfame 25-Ado-2025 · NCT05237258

Qorannoo Leukemia Myeloidii Hamaa magaalota biroo keessatti

Qorannoo biroo Rochester keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.